The Medical Research Council Myeloma IX Trial: new clinical insights on the anticancer effects of zoledronic acid in patients with multiple myeloma

Clin Lymphoma Myeloma Leuk. 2012 Feb;12(1):2-4. doi: 10.1016/j.clml.2011.03.025. Epub 2011 May 4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / therapeutic use
  • Clodronic Acid / administration & dosage
  • Clodronic Acid / therapeutic use*
  • Diphosphonates / administration & dosage
  • Diphosphonates / therapeutic use*
  • Disease-Free Survival
  • Drug Administration Schedule
  • Female
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / therapeutic use*
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Zoledronic Acid

Substances

  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Clodronic Acid
  • Zoledronic Acid